Dyne Therapeutics Inc (DYN)

Dyne Therapeutics Inc (DYN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.9B; returns 1 day -1.0%, 1 week +9.6%, 1 year -5.3%.

Dyne Therapeutics Inc. is a clinical-stage biotechnology company dedicated to discovering and advancing life-transforming therapeutics for individuals afflicted with genetically driven neuromuscular diseases.

Groups DYN belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Rare Diseases
• Duchenne Muscular Dystrophy
• Biopharmaceutical
• Life Sciences
• Clinical Stage
• Precision Medicine
• CNS Disorders

DYN financial model: income statement, cash flow and balance sheet